POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions

Abroad (travel likely)RecruitingPHASE2

Conditions

Prostate

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UF Health - Jacksonville, Jacksonville, Florida, United States
Contact: Study coordinator (Shelby Sparks) · shelby.sparks@ufhealth.org · 904-244-7340
Contact: Principal Investigator (Kethandapatti Balaji, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Metastatic Castration-Resistant Prostate Cancer (mCRPC) · Clear Cell Renal Cell Carcinoma (ccRCC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gilbert, United States · Phoenix, United States

Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA

Prostate Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hershey, United States

Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer

Prostate CA

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Nantong, China

Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

Prostate Cancer · Biochemical Recurrence

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Nanjing, China